These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 21132334)

  • 1. The use of traditional and newer calcineurin inhibitors in inflammatory bowel disease.
    Naganuma M; Fujii T; Watanabe M
    J Gastroenterol; 2011 Feb; 46(2):129-37. PubMed ID: 21132334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Steroid-unresponsive acute attacks of inflammatory bowel disease: immunomodulation by tacrolimus (FK506).
    Fellermann K; Ludwig D; Stahl M; David-Walek T; Stange EF
    Am J Gastroenterol; 1998 Oct; 93(10):1860-6. PubMed ID: 9772045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tacrolimus is safe and effective in patients with severe steroid-refractory or steroid-dependent inflammatory bowel disease--a long-term follow-up.
    Baumgart DC; Pintoffl JP; Sturm A; Wiedenmann B; Dignass AU
    Am J Gastroenterol; 2006 May; 101(5):1048-56. PubMed ID: 16573777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tacrolimus Therapy in Steroid-Refractory Ulcerative Colitis: A Review.
    Wu B; Tong J; Ran Z
    Inflamm Bowel Dis; 2020 Jan; 26(1):24-32. PubMed ID: 30980713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of infliximab as rescue therapy for ulcerative colitis refractory to tacrolimus.
    Yamamoto S; Nakase H; Matsuura M; Honzawa Y; Masuda S; Inui K; Chiba T
    J Gastroenterol Hepatol; 2010 May; 25(5):886-91. PubMed ID: 20546441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ability of different rescue therapies to save the bowel in acute, severe, steroid-refractory ulcerative colitis.
    Farkas K; Molnár T; Szepes Z
    Expert Rev Gastroenterol Hepatol; 2014 Aug; 8(6):695-702. PubMed ID: 24738535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effectiveness and safety of rescue treatments in 108 patients with steroid-refractory ulcerative colitis with sequential rescue therapies in a subgroup of patients.
    Protic M; Seibold F; Schoepfer A; Radojicic Z; Juillerat P; Bojic D; Mwinyi J; Mottet C; Jojic N; Beglinger C; Vavricka S; Rogler G; Frei P
    J Crohns Colitis; 2014 Nov; 8(11):1427-37. PubMed ID: 24908178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy and safety of infliximab and calcineurin inhibitors in steroid-refractory UC patients: A meta-analysis.
    Zhao HN; Jiang M; Sun MJ; Dai C
    Saudi J Gastroenterol; 2021; 27(4):191-200. PubMed ID: 34380865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and Efficacy of Combination Treatment With Calcineurin Inhibitors and Vedolizumab in Patients With Refractory Inflammatory Bowel Disease.
    Christensen B; Gibson PR; Micic D; Colman RJ; Goeppinger SR; Kassim O; Yarur A; Weber CR; Cohen RD; Rubin DT
    Clin Gastroenterol Hepatol; 2019 Feb; 17(3):486-493. PubMed ID: 29751166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclosporine in steroid refractory acute severe colitis.
    Kumar NS; Khosla R; Makharia GK
    Trop Gastroenterol; 2014 Aug; 35 Suppl 1():S21-8. PubMed ID: 25735123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medium-term results of oral tacrolimus treatment in refractory inflammatory bowel disease.
    Ng SC; Arebi N; Kamm MA
    Inflamm Bowel Dis; 2007 Feb; 13(2):129-34. PubMed ID: 17206694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclosporine or infliximab as rescue therapy in severe refractory ulcerative colitis: early and long-term data from a retrospective observational study.
    Mocciaro F; Renna S; Orlando A; Rizzuto G; Sinagra E; Orlando E; Cottone M
    J Crohns Colitis; 2012 Jul; 6(6):681-6. PubMed ID: 22398101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacologic therapies for severe steroid refractory hospitalized ulcerative colitis: A network meta-analysis.
    Komaki Y; Komaki F; Micic D; Yamada A; Suzuki Y; Sakuraba A
    J Gastroenterol Hepatol; 2017 Jun; 32(6):1143-1151. PubMed ID: 27957761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucosal healing with oral tacrolimus is associated with favorable medium- and long-term prognosis in steroid-refractory/dependent ulcerative colitis patients.
    Miyoshi J; Matsuoka K; Inoue N; Hisamatsu T; Ichikawa R; Yajima T; Okamoto S; Naganuma M; Sato T; Kanai T; Ogata H; Iwao Y; Hibi T
    J Crohns Colitis; 2013 Dec; 7(12):e609-14. PubMed ID: 23680174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunosuppression in inflammatory bowel disease: When, how and how long?].
    Gross V
    Dtsch Med Wochenschr; 2012 Sep; 137(37):1803-5. PubMed ID: 22956222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term comparative efficacy of cyclosporine- or infliximab-based strategies for the management of steroid-refractory ulcerative colitis attacks.
    Naves JE; Llaó J; Ruiz-Cerulla A; Romero C; Mañosa M; Lobatón T; Cabré E; Garcia-Planella E; Guardiola J; Domènech E
    Inflamm Bowel Dis; 2014 Aug; 20(8):1375-81. PubMed ID: 25046008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclosporine A for induction of remission in severe ulcerative colitis.
    Shibolet O; Regushevskaya E; Brezis M; Soares-Weiser K
    Cochrane Database Syst Rev; 2005 Jan; (1):CD004277. PubMed ID: 15674937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy of oral tacrolimus in patients with moderate/severe ulcerative colitis not receiving concomitant corticosteroid therapy.
    Inoue T; Murano M; Narabayashi K; Okada T; Nouda S; Ishida K; Kawakami K; Abe Y; Takeuchi T; Tokioka S; Umegaki E; Higuchi K
    Intern Med; 2013; 52(1):15-20. PubMed ID: 23291669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclosporine therapy in inflammatory bowel disease: short-term and long-term results.
    Gurudu SR; Griffel LH; Gialanella RJ; Das KM
    J Clin Gastroenterol; 1999 Sep; 29(2):151-4. PubMed ID: 10478875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infliximab or cyclosporine for acute severe ulcerative colitis: a retrospective analysis.
    Dean KE; Hikaka J; Huakau JT; Walmsley RS
    J Gastroenterol Hepatol; 2012 Mar; 27(3):487-92. PubMed ID: 22098019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.